| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From The Burnham Institute,* La Jolla; and the Veteran’s Affairs Medical Center/University of California at San Diego, San Diego, California
 |
Abstract |
|---|
 Top Abstract Materials and MethodsResultsDiscussionReferences |
|---|
Three molecules have been identified as central regulators of extracellular PPi and Pi levels (Table 1)
, ie, tissue-nonspecific alkaline phosphatase (TNAP), which hydrolyzes PPi,6-10
nucleotide pyrophosphatase phosphodiesterase 1 (NPP1), which generates PPi from nucleoside triphosphates,11-13
and the multiple-pass transmembrane protein ANK, which mediates intracellular to extracellular channeling of PPi.14,15
|
NPP1 serves as a physiological inhibitor of calcification, at least in part by generating PPi.11-13,21 In human infants, severe NPP1 deficiency states were recently linked to a syndrome of spontaneous infantile arterial and periarticular calcification.22,23 NPP1 knockout mice (Enpp1-/-) also known as tiptoe walking (ttw/ttw) mice, spontaneously develop progressive ankylosing intervertebral and peripheral joint hyperostosis and articular cartilage calcification.24-29 Despite the different manner in which NPP1 and ANK supply PPi to bone matrix, a similar phenotype is associated with a naturally occurring truncation mutation of the C-terminal cytosolic domain of ANK that appears to attenuate PPi channeling in ank/ank mutant mice.14,15,30
The TNAP-, NPP1-, and ANK-deficient mice all have altered levels of PPi and thus, these mice are valuable tools to further understand the function of PPi in the process of bone mineralization. Central to our understanding of this process is not only how osteoblasts and chondrocytes make and dispose of PPi, but what downstream effects PPi has on bone forming cells, in particular osteoblast gene expression. We have previously shown that crossbreeding the Akp2-/- and the Enpp1-/- mice rescues the PPi levels of the single-deficient animals, resulting in a correction of the mineralization defects.10 Given the similarity in function of NPP1 and ANK, and also the similarity in phenotype of the deficient mice, here we investigated whether simultaneously affecting TNAP and ANK function would also ameliorate the mineralization defects of the single-deficient mice as previously observed for the [Akp2-/-; Enpp1-/-] double deficiency. We also examined the effects of PPi on osteoblastic gene expression. It is well established that during the process of normal bone differentiation and subsequent deposition of mineral, a number of osteoblast marker genes are expressed in a defined spatial and temporal manner. We have recently shown that osteopontin (OPN), a putative inhibitor of mineralization,31-33 is down-regulated in the hypermineralized Enpp1 and ank/ank mice.29 Here we investigated the changes in OPN expression in the single- and double-knockout mice and the effects of TNAP-, ANK-, and NPP1-mediated alterations in PPi levels on both OPN expression and hydroxyapatite deposition. Our data have enabled us to build a model of the concerted action of these three molecules in controlling normal mineralization that also explains the pathological abnormalities in hypo- and hypermineralization disorders.
|
Materials and Methods |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
All routine chemicals were of an analytical grade from Sigma (St. Louis, MO), unless otherwise indicated.
Generation and Maintenance of Akp2-/-, Enpp1-/-, and [Akp2-/-; ank/ank] Mice
The generation and characterization of Akp2-/-, Enpp1-/-, ank/ank, and [Akp2-/-; Enpp1-/-] mice has been reported previously.10,19,20,26 Mice carrying the ank mutation14,15 were purchased from The Jackson Laboratory (Bar Harbor, ME) and bred into the Akp2-/- strain to generate [Akp2-/-; ank/ank] double-deficient mice. To determine genotypes, genomic DNA was isolated from tails and analyzed using polymerase chain reaction (PCR) protocols.10,29 Southern blots were used to confirm the double-knockout genotypes.
Tissue Preparation and Morphological Analysis
Whole-mount skeletal preparations were prepared by removal of skin and viscera of mice followed by a 1-week immersion in 100% ethanol, followed by 100% acetone. Samples were then transferred to a 100% ethanol solution containing 0.01% Alizarin Red S, 0.015% Alcian Blue 8GX, and 0.5% acetic acid for 3 weeks. Samples were then destained with 1% (v/v) KOH/50% glycerol solution. Cleared samples were stored in 100% glycerol. For analysis of mineral deposition, the lumbar spines from 10-day-old mice were fixed in 10% neutral buffered formalin for 5 days. After washing in phosphate-buffered saline-based sucrose solutions, samples were embedded in optimal cutting temperature (OCT) solution. Sections (16 µm) were stained using the von Kossa procedure as previously described.34 The degree of mineralization of the spines was quantified by examining the vertebral apophyses of the von Kossa-stained lumbar sections from each respective genotype. The number of ossification centers containing visible mineral deposits (stained black/brown) versus those containing no deposits, was determined using low (x16) magnification. Three sections, each containing a minimum of five vertebrae, were counted per mouse and the percentage of mineralized apophyses was plotted as a function of the Akp2 and ANK genotypes. The number of mice examined for each genotype were: [Akp2+/+; Ank/Ank], n = 2; [Akp2+/+; Ank/ank], n = 7; [Akp2+/+; ank/ank], n = 2; [Akp2+/-; Ank/Ank], n = 8; [Akp2+/-; Ank/ank], n = 9; [Akp2+/-; ank/ank], n = 3; [Akp2-/-; Ank/Ank], n = 2; [Akp2-/-; Ank/ank], n = 9; and [Akp2-/-; ank/ank], n = 2. For immunohistochemical analysis, mouse skeletal tissues were dissected and fixed in 10% neutral buffered formalin for 2 days and then decalcified in 4% hydrochloric acid, processed for histology, and embedded in paraffin. For detection of OPN, sections were deparaffinized, blocked with 10% goat serum for 20 minutes, and incubated overnight at 4°C with rabbit polyclonal antibody to OPN (Chemicon, Temecula, CA). Washed sections were incubated for 1 hour at 22°C with biotinylated goat anti-rabbit IgG followed by a 1-hour incubation with peroxidase-conjugated avidin. Peroxidase activity was detected using the Fast DAB staining kit (Sigma), according to the manufacturer’s instructions.
Isolation and Culture of Primary Calvarial Osteoblasts
Mouse calvarial cells were isolated from 3-day-old mice through sequential collagenase digestion, as previously described.10
Calvarial cells of the same genotype were pooled and plated at a density of 4 x 104 cells/cm2 in 
-MEM (Life Technologies, Inc., Grand Island, NY), supplemented with 10% fetal calf serum, 1% penicillin/streptomycin, and 1% L-glutamine. The cells were incubated in a humidified atmosphere of 5% CO2 in air at 37°C. The medium was completely replaced every third day. For studies under mineralizing conditions, media were supplemented with ß-glycerophosphate (10 mmol/L) and L-ascorbic acid (50 µg/ml).
Analysis of PPi Levels
PPi levels were determined by differential adsorption on activated charcoal of UDP-D-[6-3H]glucose (Amersham Biosciences, Piscataway, NJ) from the reaction product of 6-phospho[6-3H]gluconate, as previously described.12,13 To determine intracellular PPi, washed cells were heated at 65°C for 45 minutes, washed again, and lysed in 1% Triton X-100, 1.6 mmol/L MgCl2, 0.2 mol/L Tris, pH 8.1 (lysis buffer).12 Extracellular PPi was determined from conditioned media treated in the same manner.12 We determined cell protein, and specific activity of nucleosidetriphosphate pyrophosphohydrolase and alkaline phosphatase activities as described.13
Western Blot Analysis of NPP1 and ANK Localization
Primary calvarial osteoblasts were treated with mineralization media for 14 days and the cell-associated MVs were collected by collagenase digestion for 2 hours at 37°C. The supernatant was collected and initially centrifuged at 20,000 x g for 20 minutes at 4°C to pellet cellular debris. This was followed by centrifugation at 100,000 x g for 1 hour to isolate the MV fraction, which was resuspended in Hanks’ balanced salt solution. Fifty µg of protein was used for Western blotting from both the MV fraction as well as the cell lysates collected in the first centrifugation. Western blot analysis was performed as previously described using rabbit anti-mouse ANK,35 and rabbit anti-mouse NPP1.15
RNA Isolation and Reverse Transcriptase (RT)-PCR
Total RNA was isolated from osteoblasts using 0.5 ml of Trizol (Life Technologies)/35-mm dish and was reverse-transcribed using the Titanium One-Step RT-PCR kit (Invitrogen, San Diego, CA) according to the manufacturer’s instructions. The primers used were as follows: Mouse Opn (5'-CTCCCGGAGAAAGTGACTGA-3', 5'-GACCTCAGAAGATGAACTAT-3'), mouse Akp2 (5'-AGTCCGTGGGCATTGTGACTA-3', 5'-TGCTGCTCCACTCACGTC GAT-3'), mouse Ank (5'-CTAGCAGGGTTTGTGGGAGAA-3', 5-TTTATGAAGCAGGGG CGTGAA-3), mouse Enpp1(5'-GCTACAGCTTTCTAGCCATGA-3', TTAATCCAAGCC CAGGTCCTT-3'). Mouse ß-actin primers were used as a loading control. The PCR products were separated by electrophoresis on 1% agarose gels and werevisualized by ethidium bromide staining with UV light illumination.
OPN Enzyme-Linked Immunosorbent Assay
To measure OPN protein levels, we developed an enzyme-linked immunosorbent assay based on a previously published method36 using plates coated with a monoclonal antibody to native OPN (Chemicon) using a 1:2500 dilution of OPN antibody in 100 µl/well 0.1 mol/L sodium bicarbonate, pH 9.0, at 4°C overnight. Wells were blocked with 10 mmol/L Tris, 150 mmol/L NaCl, and 0.05% Tween-20, pH 8.0, for 1 hour at 22°C. Samples, diluted in 1% bovine serum albumin, 10 mmol/L Tris, and 150 mmol/L NaCl, pH 8.0, were added to the wells and incubated for 1 hour at 37°C. Recombinant murine OPN was used as standard. Washed wells were incubated sequentially for 1 hour at 37°C with rabbit anti-OPN (1:1000, Chemicon), biotinylated goat anti-rabbit IgG (1:1000), and streptavidin conjugated with AP (1:500 dilution). Color was developed using p-nitrophenylphosphate and read at 405 nm.
|
Results |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
We have previously shown that the simultaneous deletion of the Akp2 and Enpp1 genes can rescue the mineralization defects of both the Akp2 and Enpp1 single-knockout mice.10 The transmembrane protein ANK acts as a transport channel for PPi, and therefore has a similar function to NPP1 in that it also increases extracellular PPi levels. Truncation mutation of the C-terminal intracellular domain of ANK in ank/ank mutant mice, results in a hypermineralized phenotype, called murine progressive ankylosis14,15 and these mice show remarkable similarity in phenotype to the NPP1-deficient mice.
Given this similarity in function between ANK and NPP1, we examined whether a double deficiency in both the Ank and Akp2 genes could rescue the mineralization defects of both the Akp2-/- and ank/ank mutant mice. To this end we crossbred ank/ank mutant mice to Akp2+/- heterozygote mice to obtain [Akp2-/-; ank/ank] double-mutant mice. We examined the degree of mineralization in the spines of [Akp2-/-; ank/ank] mice using von Kossa staining to detect mineral deposition because we have previously shown10
that the vertebral apophyses provide a sensitive indication of the extent of hypo- and hypermineralization. We calculated the percentage mineralization of the apophyses in both the single- and double-mutant animals (Figure 1)
. As expected, Akp2-/- mice showed a clear depression in the level of mineralization of the vertebrae, with only 10% of the vertebral apophyses mineralized. The ank/ank mutant animals had an increased level of mineralization in the spine, with 100% mineralization in comparison to 70% in wild-type controls. Mice doubly deficient in both Akp2 and Ank, showed an improvement in the levels of abnormal mineralization (80%) in comparison to the Akp2-/- single-knockout (10%) and the ank/ank mutant mice (100%). In Akp2-/- animals the level of mineralization was ameliorated by mutation of just one Ank allele in these mice as the [Akp2-/-; Ank/ank] mice showed normalized levels of mineralization, 
70%, ie, control levels. In the [Akp2-/-; ank/ank] double-mutant animals there remained a higher degree of mineralization than in control mice, but the percentages were lower than in the ank/ank mutant animals. Thus, we conclude that crossbreeding Akp2-/- mice to ank/ank mice results in a partial rescue of the abnormal mineralization of both single-mutant mice.
|
Given the partial correction of the mineralization defects that we observed in [Akp2-/-; ank/ank] mice, we next examined whether the levels of PPi were also affected in these animals. In both the Akp2-/- mice and the ank/ank mutant animals, PPi levels are altered (Figure 2)
. In Akp2-/- mice elevated levels of PPi result from the lack of the pyrophosphatase activity of TNAP whereas in ank/ank mutant mice there is a decrease in extracellular levels of PPi because of the absence of ANK-mediated transport of PPi across the plasma membrane. The ank/ank mutant mice although displaying decreased levels of extracellular PPi, have increased levels of intracellular PPi.
|
. Interestingly, we found that the extracellular levels of PPi were significantly normalized in the [Akp2-/-; ank/ank] osteoblasts during the latter stages of differentiation. However, for intracellular levels of PPi, although there is a tendency toward normalization, the changes are not statistically significant.
It seems, from the partial correction in both skeletal mineralization and PPi concentrations, that the Ank and Enpp1 deficiencies may not be identical because crossbreeding ank/ank mice to Akp2-/- mice does not result in the same degree of phenotypic rescue observed in the [Akp2-/-; Enpp1-/-] double-knockout mice. This led us to compare more closely the degree of mineralization in both the Enpp1-/- and ank/ank mutant animals. Whole mount examination of their Alizarin Red-stained skeletons consistently revealed subtle differences in the soft tissue ossification phenotypes of these mice. It appears that the Enpp1-knockout mice have a more severe phenotype than ank/ank mutant mice (Figure 3)
. The Enpp1-/- mice display soft tissue mineralization in the metatarsal bones (Figure 3, B and E)
as well as ossification of the Achilles tendon (Figure 3, H and K)
, whereas the ank/ank mutants, although clearly displaying hyperossification (Figure 3C)
, do not have the same degree of hypermineralization as observed in the Enpp1-/- mice.
|
. This implies that NPP1 and ANK have distinct effects on extracellular PPi concentrations, and therefore on mineralization. This was confirmed by examination of the ANK and NPP1 localization in osteoblasts and MVs. Western blot analysis of ANK and NPP1 localization revealed that both are present in osteoblasts but only NPP1 is present in MVs (Figure 5)
. This suggests that the localization of NPP1 and ANK to different microenvironments might account for the different mineralization abnormalities and degree of rescue observed in the Enpp1-/- and ank/ank models.
|
|
We next investigated the downstream events associated with either an increase or a decrease of extracellular PPi. The mineralization defects observed in the Akp2-, Enpp1-, and Ank-deficient mice suggest a defect in the osteoblast compartment, because it is in the osteoblast that the process of bio-mineralization is initiated. During the process of normal bone mineralization a number of osteoblast marker genes are expressed in a well-defined spatial and temporal manner. We have previously shown that one of these markers, OPN, which is an inhibitor of mineralization,31,37
is depressed at the mRNA level in osteoblasts isolated from Enpp1-/- mice.29
We therefore examined the expression of Opn in calvarial osteoblast cells isolated from Akp2-/- and ank/ank mice as well as the [Akp2-/-; ank/ank] double-deficient mice (Figure 6A)
. We found that throughout the 21-day period of differentiation in a bone nodule assay, Opn levels were altered in both the Akp2-/- and the ank/ank mice in comparison to wild-type controls. In Akp2-/- calvarial osteoblasts, Opn expression was markedly increased throughout the course of the differentiation period. In contrast, in ank/ank osteoblasts cells, Opn expression was comparable to that of wild-type cells during the initial stages of differentiation, up to day 3, but was completely shut-off during the later stages. Interestingly, we observed a normalization of Opn expression in [Akp2-/-; ank/ank] mice, although the levels were not restored to those of wild-type controls. The partial normalization in Opn levels in the [Akp2-/-; ank/ank] osteoblasts parallels the partial correction observed in the mineralization defects and PPi concentrations.
|
. Addition of exogenous PPi to wild-type calvarial osteoblasts caused an increase in Opn mRNA levels in response to PPi. This effect is because of PPi, and not its hydrolysis product Pi because at these concentrations Pi did not affect OPN expression in the wild-type osteoblast cells. Interestingly, PPi levels affect not only Opn expression, but also Enpp1 and Ank expression. In response to PPi treatment, both Enpp1 and Ank expression are depressed, thus suggesting that both NPP1 and ANK can influence Opn expression through their regulation of PPi concentrations. These effects on Opn expression were not only observed at the mRNA level, but were also reflected in changes in serum levels of circulating OPN in the various single- and double-mutant mouse models (Figure 7A)
. This analysis revealed a similar pattern of OPN changes as observed at the mRNA level in that serum levels of OPN were elevated in Akp2-/- mice and depressed in ank/ank mice. In the [Akp2-/-; ank/ank] double-knockout mice we observed a normalization of serum OPN levels. Furthermore, we measured serum OPN in the Enpp1-/- mice and observed a similar reduction in concentration as that observed in the ank/ank mice. As with the [Akp2-/-; ank/ank] mice, we observed a significant correction in serum OPN levels in the [Akp2-/-; Enpp1-/-] double-knockout mice. In addition to serum level of OPN, we also looked at the in situ localization of OPN in bone. Immunohistochemical analysis of spine sections from these mice revealed changes in OPN expression that paralleled the mRNA data as well as the changes in serum levels of OPN (Figure 7B)
. Akp2-/- mice display an increase in OPN expression in the vertebral apophyses in comparison to wild-type animals, whereas in analogous locations in Enpp1-/- and ank/ank mice, OPN expression is lower compared to wild-type controls. The [Akp2-/-; Enpp1-/-] and [Akp2-/-; ank/ank] mice display OPN levels comparable to control animals (Figure 7B)
.
|
. OPN has previously been shown to inhibit hydroxyapatite crystal formation and it is thought that it physically limits crystal growth in bone. We show here that in mice lacking TNAP, there is an increase in OPN levels that results from the increased transcription of the Opn gene induced by elevated concentrations of extracellular PPi. Thus, hypomineralization in the Akp2-/- mice likely ensues as a result of the combined effect of abnormally high levels of both of these mineralization inhibitors, ie, PPi and OPN. In mice lacking NPP1, and in ANK-deficient animals, the depressed levels of PPi lead to reduced levels of OPN, and the decrease in the levels of both mineralization inhibitors leads to an overall increase in mineralization.
|
|
Discussion |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
We have previously shown that the simultaneous deletion of the Akp2 and Enpp1 genes normalizes PPi levels thereby causing a concomitant correction in the mineralization defects of the single-knockout animals.10 These data were significant in that they provided clear confirmation of the previously proposed pyrophosphatase role for TNAP in bone tissue6-9 but also pointed to both NPP1 and TNAP as therapeutic targets in the treatment of mineralization diseases such as hypophosphatasia and osteoarthritis. Given that the ANK protein functions like NPP1, albeit in a different manner, to increase extracellular PPi levels, we examined whether an analogous crossbreeding of ank/ank mice to Akp2-/- mice would correct the mineralization defects of the Akp2-/- and ank/ank single-deficient mice. We show here that the [Akp2-/-; ank/ank] mice displayed a partial correction in the hypo- and hypermineralization phenotypes as measured by the extent of mineralization in the vertebral apophyses of these mice. This partial normalization of mineralization was paralleled by a partial correction in PPi levels. Interestingly, we observed a normalization of extracellular PPi levels in the [Akp2-/-; ank/ank] mice, but the intracellular PPi concentrations in these mice remained abnormal. Presumably this residual abnormality in PPi levels prevented the complete normalization of mineralization in the double-knockout mice, illustrating the importance of a balance between the intra- and extracellular concentrations of PPi in regulating hydroxyapatite deposition. In this context a question that remains unanswered is how ank/ank osteoblasts are able to respond to a pulse of extracellular PPi with an increase in Opn expression, given the high concentration of intracellular PPi inherent in these cells.29
The difference in phenotypic abnormalities between the [Akp2-/-; Enpp1-/-] and the [Akp2-/-; ank/ank] mice led us to examine in detail the degree of hypermineralization in both the Enpp1-/- and ank/ank mutants as well as in the [Enpp1-/-; ank/ank] double-mutant mice. We determined that there are subtle differences in the hypermineralization defects between the ank/ank and Enpp1-/- mice and that the ectopic calcification and soft tissue ossification of the Enpp1-/- mice is more severe than that of the ank/ank mice. Furthermore, the degree of soft-tissue ossification was further increased in the [Enpp1-/-; ank/ank] double-mutants compared to the single-deficient mice, thus indicating that these two molecules act differently because the absence of both results in an additive effect on hypermineralization. The fact that NPP1 localizes to MVs but that ANK is excluded from this extracellular compartment further validates this conclusion.
It is within the membrane-limited microenvironment of the MV that initial mineral accumulation takes place, followed by propagation of the hydroxyapatite crystals that eventually burst through the MV membrane and become exposed to the extracellular matrix.1 It is well established that MVs are enriched in TNAP3,4 and it is now clear that TNAP is essential for the second phase of mineral deposition because MVs from hypophosphatasia patients,38 or from Akp2-/- mice,39 contain mineral that does not propagate. The absence of ANK in MVs suggests that its PPi-channeling function is not required for initiation and propagation of hydroxyapatite crystals and that it is TNAP and NPP1 that are responsible for this process. Thus, the absence of NPP1 in the MVs of Enpp1-/- osteoblasts results in a greater deficit in PPi levels than an absence of ANK, leading to the more severe hypermineralization observed in Enpp1-/- mice. The deficit in extracellular PPi production in ank/ank mice results only from the decreased activity of ANK in the osteoblasts. Presumably there is still a sufficient amount of PPi within the MVs of the ank/ank mice (provided by NPP1) such that the hypermineralization phenotype is not as severe as in Enpp1-/- mice. Furthermore these data explain the only partial rescue in the [Akp2-/-; ank/ank] mice because in these animals there is an excess PPi in the MV (because of NPP1) that will not be hydrolyzed in the absence of TNAP, ie, the levels of PPi in MVs are not normalized in the [Akp2-/-; ank/ank] mice, and thus full rescue does not ensue. In the [Akp2-/-; Enpp1-/-] mice however, there is no excess of PPi in the MVs and so mineral deposition proceeds normally.
Although the Akp2-/-, Enpp1-/-, and ank/ank mice all have severe mineralization phenotypes associated with abnormal PPi levels, it is not known precisely how PPi inhibits the mineralization capacity of osteoblasts. For osteoblasts to lay down mineral, a number of osteoblastic genes must be turned on and off in a well-defined sequence. Several of these characteristic matrix proteins can affect hydroxyapatite deposition and growth.40 One of these factors is OPN, a secreted glycoprotein that has been suggested to physically limit hydroxyapatite formation and deposition both in vivo31,37 and in vitro.41 We have recently shown that OPN may be a potential modulator of PPi effects.29 In this study we examined the effects of PPi on OPN expression in the three relevant mouse models of mineralization defects. In ank/ank and Enpp1-/- primary mouse osteoblasts, OPN expression is inhibited in comparison to control levels. We hypothesized that because TNAP has a crucial role in regulating PPi levels, OPN levels might also be altered in Akp2-/- mice. In fact, we found that Akp2-/- mice showed significant elevations in OPN expression at the mRNA level. A similar pattern in serum protein levels of OPN was observed, with both Enpp1-/- and ank/ank mice showing a decrease in serum OPN, whereas Akp2-/- mice had increased levels. Interestingly, OPN levels appeared normal in [Akp2-/-; Enpp1-/-] and [Akp2-/-; ank/ank] double homozygote mice, which paralleled either a full or partial normalization of mineralization defects and PPi levels, thus suggesting that PPi can regulate OPN expression. It should be noted that the range of OPN concentrations measured in this study (10 to 120 pg/ml) are lower than those reported in other studies (100 to 5000 ng/ml).42,43 This is most likely because of our using serum rather than plasma for our measurements, because it is known that serum levels of OPN are lower than plasma levels.36
To confirm that the depression of OPN in Enpp1-/- and ank/ank, and the increase in OPN in Akp2-/- mice is because of changes in PPi concentrations we examined the effects of exogenous addition of PPi to wild-type osteoblasts. Exogenous PPi resulted in an induction of Opn expression, and in addition, PPi down-regulated expression of both Enpp1 and Ank, although PPi treatment had no significant effect on Akp2 expression. We determined that this modulation of Opn expression is in fact because of PPi and not its hydrolysis product Pi. It has been previously shown that Pi can induce Opn expression,44
however in our study the end concentrations of Pi, resulting from the complete hydrolysis of the added PPi, are significantly lower (500 pmol/L) than that used in the study of Beck and colleagues44
(10 mmol/L). We chose a PPi concentration of 500 pmol/L because our previous data has revealed this concentration as the difference between wild-type and Enpp1-/- mice. Therefore, our data supports a direct regulation of Opn by PPi, the product of ANK and NPP1 function, and further suggests a negative feedback pathway by which PPi inhibits Ank and Enpp1 expression.
We therefore conclude that under normal conditions the concerted action of TNAP, NPP1, and ANK regulate intra- and extracellular PPi levels and that this tight regulation is required for controlled mineral deposition. Hypophosphatasia in the Akp2 knockout mice arises from deficits in TNAP activity, resulting in an increase in extracellular PPi levels and a concomitant increase in OPN levels; the combined effect of both these inhibitory factors leads to hypomineralization. This conclusion suggests the testable hypothesis that the simultaneous ablation of the Opn and the Akp2 gene should lead to an improvement in the hypomineralization abnormalities of the Akp2-/- mice. A comparison of the [Akp2-/-; Opn-/-], [Akp2-/-; Enpp1-/-], and [Akp2-/-; ank/ank] mice should give an indication as to the relative contributions of both OPN and PPi in establishing the rickets/osteomalacia phenotype of the Akp2-/- mice.
In turn, an NPP1 or ANK deficiency leads to a decrease in the PPi levels that cause a decrease in the OPN pool. Thus the simultaneous decrease of both these inhibitory factors, ie, PPi and OPN, results in the hypermineralization abnormalities in the Enpp1-/- and ank/ank mice. Because the mineralization defects in Akp2-/- mice, along with elevated PPi and OPN levels, are normalized to varying extents by ablation of either the NPP1 or ANK gene, we conclude that both NPP1 and ANK represent rational therapeutic targets for hypophosphatasia, a disease for which to date there is no treatment. In addition, our current data provide further proof that TNAP is a potential target for hypermineralization diseases such as osteoarthritis and ankylosis.
|
Acknowledgements |
|---|
; and Dr. Agi Grigoriadis for critical reading of the manuscript. |
Footnotes |
|---|
Supported by the National Institutes of Health (grants AR47908, DE12889, and P01 AGO-7996) and the Research Service of the Department of Veterans Affairs.
D.H. and L.H. contributed equally to this work.
Accepted for publication December 9, 2003.
|
References |
|---|
|
TopAbstractMaterials and MethodsResultsDiscussionReferences |
|---|
This article has been cited by other articles:
 |
|
 |
|
  K. A. Johnson, W. Yao, N. E. Lane, P. Naquet, and R. A. Terkeltaub Vanin-1 Pantetheinase Drives Increased Chondrogenic Potential of Mesenchymal Precursors in ank/ank Mice Am. J. Pathol., February 1, 2008; 172(2): 440 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Moochhala, J. A. Sayer, G. Carr, and N. L. Simmons Renal calcium stones: insights from the control of bone mineralization Exp Physiol, January 1, 2008; 93(1): 43 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Scatena, L. Liaw, and C. M. Giachelli Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2302 - 2309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Schiffrin, M. L. Lipman, and J. F.E. Mann Chronic Kidney Disease: Effects on the Cardiovascular System Circulation, July 3, 2007; 116(1): 85 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Vistoropsky, M. Keter, I. Malkin, S. Trofimov, E. Kobyliansky, and G. Livshits Contribution of the putative genetic factors and ANKH gene polymorphisms to variation of circulating calciotropic molecules, PTH and BGP Hum. Mol. Genet., May 15, 2007; 16(10): 1233 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Kaartinen, M. Murshed, G. Karsenty, and M. D. McKee Osteopontin Upregulation and Polymerization by Transglutaminase 2 in Calcified Arteries of Matrix Gla Protein-deficient Mice J. Histochem. Cytochem., April 1, 2007; 55(4): 375 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, M. A. Brown, C. Peach, G. Russell, and B. P. Wordsworth Investigation of the role of ENPP1 and TNAP genes in chondrocalcinosis Rheumatology, April 1, 2007; 46(4): 586 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. O'Neill Pyrophosphate, Alkaline Phosphatase, and Vascular Calcification Circ. Res., July 21, 2006; 99(2): e2 - e2. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Llinas, M. Masella, T. Stigbrand, A. Menez, E. A. Stura, and M. H. Le Du Structural studies of human alkaline phosphatase in complex with strontium: Implication for its secondary effect in bones. Protein Sci., July 1, 2006; 15(7): 1691 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.B. Rutherford, B.L. Foster, T. Bammler, R.P. Beyer, S. Sato, and M.J. Somerman Extracellular phosphate alters cementoblast gene expression. J. Dent. Res., June 1, 2006; 85(6): 505 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhang, M. Balcerzak, J. Radisson, C. Thouverey, S. Pikula, G. Azzar, and R. Buchet Phosphodiesterase Activity of Alkaline Phosphatase in ATP-initiated Ca2+ and Phosphate Deposition in Isolated Chicken Matrix Vesicles J. Biol. Chem., November 4, 2005; 280(44): 37289 - 37296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Bardos, Z Szabo, M Czipri, C Vermes, M Tunyogi-Csapo, R M Urban, K Mikecz, and T T Glant A longitudinal study on an autoimmune murine model of ankylosing spondylitis Ann Rheum Dis, July 1, 2005; 64(7): 981 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Anderson, D. Harmey, N. P. Camacho, R. Garimella, J. B. Sipe, S. Tague, X. Bi, K. Johnson, R. Terkeltaub, and J. L. Millan Sustained Osteomalacia of Long Bones Despite Major Improvement in Other Hypophosphatasia-Related Mineral Deficits in Tissue Nonspecific Alkaline Phosphatase/Nucleotide Pyrophosphatase Phosphodiesterase 1 Double-Deficient Mice Am. J. Pathol., June 1, 2005; 166(6): 1711 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Murshed, D. Harmey, J. L. Millan, M. D. McKee, and G. Karsenty Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone Genes & Dev., May 1, 2005; 19(9): 1093 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
